Literature DB >> 31348728

Mastoiditis with Streptococcus pneumoniae serotype 19A in one-dose PCV13 vaccinated three-month-old infant.

B Gülhan1, S Kanik-Yuksek1, A Ozkaya-Parlakay1.   

Abstract

Pneumococcal conjugate vaccines (PCV) have been widely used in high-income countries for more than a decade, resulting in a dramatic reduction in pneumococcal disease caused by vaccine serotypes. PCV has been included in Turkey's National Immunization Programme since 2009 with PCV7 and continued with PCV13 from 2011. We presented a three-month-old infant who developed mastoiditis secondary to S. pneumoniae serotype 19A after acute otitis media.

Entities:  

Keywords:  Serotype 19A; acute otitis media; mastoiditis; pneumococcal conjugate vaccine

Mesh：

Substances：

Year:  2019        PMID： 31348728      PMCID： PMC6930092          DOI： 10.1080/21645515.2019.1627823

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


  9 in total

Review 1.  Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.

Authors:  Gail L Rodgers; Adriano Arguedas; Robert Cohen; Ron Dagan
Journal:  Vaccine       Date:  2009-04-25       Impact factor: 3.641

2.  Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001-2011 survey by the French Pneumococcal Network.

Authors:  M Kempf; E Varon; A Lepoutre; A Gravet; R Baraduc; M Brun; H Chardon; J Cremniter; J Croizé; F Dalmay; M-C Demachy; T Fosse; C Grelaud; T Hadou; F Hamdad; J-L Koeck; S Luce; S Mermond; I Patry; A Péchinot; J Raymond; A Ros; C Segonds; B Soullié; D Tandé; M Vergnaud; V Vernet-Garnier; F Wallet; L Gutmann; M-C Ploy; P Lanotte
Journal:  Clin Microbiol Infect       Date:  2014-10-12       Impact factor: 8.067

3.  Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study.

Authors:  Matthew R Moore; Ruth Link-Gelles; William Schaffner; Ruth Lynfield; Corinne Holtzman; Lee H Harrison; Shelley M Zansky; Jennifer B Rosen; Arthur Reingold; Karen Scherzinger; Ann Thomas; Ramon E Guevara; Tasneem Motala; Jeffrey Eason; Meghan Barnes; Susan Petit; Monica M Farley; Lesley McGee; James H Jorgensen; Cynthia G Whitney
Journal:  Lancet Respir Med       Date:  2016-03-14       Impact factor: 30.700

4.  [Statement of the Advisory Immunization Committee of the Chilean Society of Infectious Diseases on the emergence of serotype 19A pneumococcal infection and the use of pneumococcal conjugated vaccine in Chilean children].

Authors:  Marcela Potin; Alberto Fica; Jan Wilhem; Jaime Cerda; Lily Contreras; Carola Escobar; Gabriela Moreno; Alma Muñoz; Liliana Véliz
Journal:  Rev Chilena Infectol       Date:  2016-06       Impact factor: 0.520

5.  Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.

Authors:  Robert Cohen; Corinne Levy; Edouard Bingen; Marc Koskas; Isabelle Nave; Emmanuelle Varon
Journal:  Pediatr Infect Dis J       Date:  2012-03       Impact factor: 2.129

6.  The worldwide impact of the seven-valent pneumococcal conjugate vaccine.

Authors:  Sean P Fitzwater; Aruna Chandran; Mathuram Santosham; Hope L Johnson
Journal:  Pediatr Infect Dis J       Date:  2012-05       Impact factor: 2.129

7.  Serotype distribution of Streptococcus pneumoniae in children with invasive diseases in Turkey: 2008-2014.

Authors:  Mehmet Ceyhan; Yasemin Ozsurekci; Nezahat Gürler; Lütfiye Öksüz; Sohret Aydemir; Sengul Ozkan; Serife Yuksekkaya; Melike Keser Emiroglu; Meral Gültekin; Akgün Yaman; Abdurrahman Kiremitci; Keramettin Yanık; Arzu Karli; Hatice Ozcinar; Faruk Aydin; Gulcin Bayramoglu; Yasemin Zer; Zeynep Gulay; Efgan Dogan Gayyurhan; Mustafa Gül; Cüneyt Özakın; Hüseyin Güdücüoğlu; Duygu Perçin; Nezahat Akpolat; Candan Ozturk; Yıldız Camcıoğlu; Eda Karadağ Öncel; Melda Çelik; Laser Şanal; Hakan Uslu
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

8.  Reducing the frequency of acute otitis media by individualized care.

Authors:  Michael E Pichichero; Janet R Casey; Anthony Almudevar
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

Review 9.  Impact of conjugate pneumococcal vaccines on antibiotic resistance.

Authors:  Ron Dagan; Keith P Klugman
Journal:  Lancet Infect Dis       Date:  2008-12       Impact factor: 25.071
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.